UK markets close in 2 hours 55 minutes

Adverum Biotechnologies, Inc. (0HA3.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
5.90-8.10 (-57.86%)
As of 2:30PM GMT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 5473.5M
Enterprise value 3891.7M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)
Price/book (mrq)1.24
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 6-9.12

Trading information

Stock price history

Beta (5Y monthly) 1.49
52-week change 3N/A
S&P500 52-week change 323.92%
52-week high 313.59
52-week low 313.49
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 562.87M
Float 61.61M
% held by insiders 10.75%
% held by institutions 196.25%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2019
Most-recent quarter (mrq)30 Sep 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-17.74%
Return on equity (ttm)-31.42%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-40.17M
EBITDA -97.79M
Net income avi to common (ttm)-98.8M
Diluted EPS (ttm)-1.28
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)454.46M
Total cash per share (mrq)4.66
Total debt (mrq)31.19M
Total debt/equity (mrq)6.71
Current ratio (mrq)28.53
Book value per share (mrq)4.77

Cash flow statement

Operating cash flow (ttm)-71.9M
Levered free cash flow (ttm)-63.2M